Cocrystal Cash vs Accounts Payable Analysis

COCP Stock

USD 2.13 0.23 12.11%

Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Cash and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Cash vs Accounts Payable

Cash vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cocrystal Pharma Cash account and Accounts Payable. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Cocrystal Pharma's Cash and Accounts Payable is -0.02. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Cash and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Cocrystal Pharma are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Cash i.e., Cocrystal Pharma's Cash and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.02

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cash

Cash refers to the most liquid asset of Cocrystal Pharma, which is listed under current asset account on Cocrystal Pharma balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Cocrystal Pharma customers. The amounts must be unrestricted with restricted cash listed in a different Cocrystal Pharma account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Accounts Payable

An accounting item on the balance sheet that represents Cocrystal Pharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cocrystal Pharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 05/23/2024, Enterprise Value Multiple is likely to grow to 0.37, while Selling General Administrative is likely to drop 5,690.

	2023	2024 (projected)
Non Recurring	41.5M	36.9M
Reconciled Depreciation	412K	302.2K

Non Recurring Reconciled Depreciation

Cocrystal Pharma fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Other Current Liab	Property Plant And Equipment Net	Other Current Assets	Property Plant And Equipment Gross	Short Long Term Debt Total	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Short Term Debt
Total Assets		0.17	0.58	0.03	0.2	0.24	-0.08	0.98	-0.41	-0.06	0.55	-0.09	-0.16	0.77	-0.1	0.57	0.3	-0.44	-0.28	-0.46	-0.43	-0.14	0.68	0.41	-0.45	0.34
Total Current Liabilities	0.17		-0.32	0.43	0.6	0.04	-0.41	0.24	0.05	-0.4	0.11	-0.37	-0.65	0.45	-0.35	0.14	0.86	0.18	0.49	0.01	0.16	-0.36	0.29	0.77	0.12	0.84
Total Stockholder Equity	0.58	-0.32		-0.21	-0.22	0.5	0.17	0.53	-0.67	0.16	0.68	0.14	0.53	-0.06	0.13	0.68	-0.24	-0.38	-0.26	-0.32	-0.51	0.12	0.5	-0.26	-0.51	-0.31
Net Debt	0.03	0.43	-0.21		0.75	0.05	-0.99	0.24	-0.14	-0.99	0.09	-0.8	-0.66	0.19	-0.99	0.13	0.29	0.05	-0.08	-0.33	0.48	0.32	0.33	0.26	0.44	0.48
Retained Earnings	0.2	0.6	-0.22	0.75		-0.08	-0.75	0.35	-0.11	-0.74	0.13	-0.51	-0.9	0.39	-0.74	0.23	0.47	-0.04	-0.04	-0.4	0.6	-0.17	0.31	0.47	0.6	0.77
Accounts Payable	0.24	0.04	0.5	0.05	-0.08		-0.02	0.24	-0.34	-0.02	0.41	-0.04	0.28	-0.08	-0.04	0.39	-0.2	0.34	-0.31	0.24	-0.01	-0.06	-0.04	-0.33	-0.05	-0.21
Cash	-0.08	-0.41	0.17	-0.99	-0.75	-0.02		-0.29	0.17	1.0	-0.12	0.8	0.65	-0.22	1.0	-0.17	-0.32	0.06	0.06	0.43	-0.42	-0.31	-0.41	-0.31	-0.38	-0.5
Non Current Assets Total	0.98	0.24	0.53	0.24	0.35	0.24	-0.29		-0.43	-0.27	0.55	-0.25	-0.29	0.78	-0.31	0.59	0.34	-0.44	-0.29	-0.53	-0.32	-0.07	0.73	0.45	-0.35	0.43
Non Currrent Assets Other	-0.41	0.05	-0.67	-0.14	-0.11	-0.34	0.17	-0.43		0.17	-0.96	0.18	-0.17	0.02	0.18	-0.96	0.02	0.24	0.1	0.3	0.16	-0.28	-0.43	0.09	0.19	0.02
Cash And Short Term Investments	-0.06	-0.4	0.16	-0.99	-0.74	-0.02	1.0	-0.27	0.17		-0.12	0.8	0.64	-0.19	1.0	-0.17	-0.31	0.06	0.05	0.42	-0.42	-0.32	-0.4	-0.29	-0.39	-0.49
Common Stock Total Equity	0.55	0.11	0.68	0.09	0.13	0.41	-0.12	0.55	-0.96	-0.12		-0.19	0.12	0.15	-0.13	0.98	0.15	-0.23	-0.04	-0.25	-0.23	0.11	0.46	0.07	-0.27	0.12
Common Stock Shares Outstanding	-0.09	-0.37	0.14	-0.8	-0.51	-0.04	0.8	-0.25	0.18	0.8	-0.19		0.46	-0.22	0.78	-0.15	-0.34	0.01	-0.12	0.15	-0.34	-0.4	-0.24	-0.27	-0.28	-0.42
Other Stockholder Equity	-0.16	-0.65	0.53	-0.66	-0.9	0.28	0.65	-0.29	-0.17	0.64	0.12	0.46		-0.59	0.64	0.04	-0.56	-0.02	-0.01	0.28	-0.56	0.24	-0.18	-0.62	-0.55	-0.84
Total Liab	0.77	0.45	-0.06	0.19	0.39	-0.08	-0.22	0.78	0.02	-0.19	0.15	-0.22	-0.59		-0.21	0.17	0.55	-0.22	-0.14	-0.29	-0.14	-0.26	0.43	0.7	-0.17	0.65
Total Current Assets	-0.1	-0.35	0.13	-0.99	-0.74	-0.04	1.0	-0.31	0.18	1.0	-0.13	0.78	0.64	-0.21		-0.18	-0.26	0.08	0.13	0.45	-0.42	-0.31	-0.41	-0.26	-0.39	-0.46
Common Stock	0.57	0.14	0.68	0.13	0.23	0.39	-0.17	0.59	-0.96	-0.17	0.98	-0.15	0.04	0.17	-0.18		0.16	-0.28	-0.07	-0.36	-0.2	0.06	0.53	0.1	-0.23	0.17
Other Current Liab	0.3	0.86	-0.24	0.29	0.47	-0.2	-0.32	0.34	0.02	-0.31	0.15	-0.34	-0.56	0.55	-0.26	0.16		-0.25	0.67	-0.26	-0.13	-0.38	0.49	0.96	-0.19	0.9
Property Plant And Equipment Net	-0.44	0.18	-0.38	0.05	-0.04	0.34	0.06	-0.44	0.24	0.06	-0.23	0.01	-0.02	-0.22	0.08	-0.28	-0.25		-0.21	0.87	0.54	0.08	-0.67	-0.38	0.51	-0.23
Other Current Assets	-0.28	0.49	-0.26	-0.08	-0.04	-0.31	0.06	-0.29	0.1	0.05	-0.04	-0.12	-0.01	-0.14	0.13	-0.07	0.67	-0.21		-0.01	-0.25	-0.19	0.13	0.54	-0.28	0.4
Property Plant And Equipment Gross	-0.46	0.01	-0.32	-0.33	-0.4	0.24	0.43	-0.53	0.3	0.42	-0.25	0.15	0.28	-0.29	0.45	-0.36	-0.26	0.87	-0.01		0.28	0.04	-0.76	-0.4	0.23	-0.38
Short Long Term Debt Total	-0.43	0.16	-0.51	0.48	0.6	-0.01	-0.42	-0.32	0.16	-0.42	-0.23	-0.34	-0.56	-0.14	-0.42	-0.2	-0.13	0.54	-0.25	0.28		0.03	-0.51	-0.2	0.98	0.18
Net Receivables	-0.14	-0.36	0.12	0.32	-0.17	-0.06	-0.31	-0.07	-0.28	-0.32	0.11	-0.4	0.24	-0.26	-0.31	0.06	-0.38	0.08	-0.19	0.04	0.03		0.02	-0.38	-0.02	-0.42
Good Will	0.68	0.29	0.5	0.33	0.31	-0.04	-0.41	0.73	-0.43	-0.4	0.46	-0.24	-0.18	0.43	-0.41	0.53	0.49	-0.67	0.13	-0.76	-0.51	0.02		0.55	-0.51	0.43
Non Current Liabilities Total	0.41	0.77	-0.26	0.26	0.47	-0.33	-0.31	0.45	0.09	-0.29	0.07	-0.27	-0.62	0.7	-0.26	0.1	0.96	-0.38	0.54	-0.4	-0.2	-0.38	0.55		-0.23	0.91
Inventory	-0.45	0.12	-0.51	0.44	0.6	-0.05	-0.38	-0.35	0.19	-0.39	-0.27	-0.28	-0.55	-0.17	-0.39	-0.23	-0.19	0.51	-0.28	0.23	0.98	-0.02	-0.51	-0.23		0.15
Short Term Debt	0.34	0.84	-0.31	0.48	0.77	-0.21	-0.5	0.43	0.02	-0.49	0.12	-0.42	-0.84	0.65	-0.46	0.17	0.9	-0.23	0.4	-0.38	0.18	-0.42	0.43	0.91	0.15

Click cells to compare fundamentals

Cocrystal Pharma Account Relationship Matchups

Cocrystal Pharma fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	28.5M	54.2M	79.4M	40.8M	31.3M	29.7M
Total Current Liabilities	2.3M	1.4M	1.5M	1.2M	3.3M	2.7M
Total Stockholder Equity	25.7M	52.5M	77.5M	39.6M	26.4M	42.6M
Net Debt	(6.6M)	(32.4M)	(58.2M)	(36.8M)	(24.6M)	(23.3M)
Retained Earnings	(235.3M)	(244.9M)	(259.1M)	(297.9M)	(315.9M)	(300.1M)
Accounts Payable	1.5M	657K	578K	614K	1.2M	931.8K
Cash	7.4M	33.0M	58.7M	37.1M	26.4M	27.7M
Non Current Assets Total	20.3M	20.2M	20.1M	662K	2.2M	2.1M
Non Currrent Assets Other	(293K)	40K	50K	46K	46.0K	48.3K
Cash And Short Term Investments	7.4M	33.0M	58.7M	37.1M	26.4M	27.7M
Common Stock Total Equity	24K	30K	36K	71K	81.7K	152.4K
Common Stock Shares Outstanding	31.9M	55.2M	88.4M	8.1M	9.7M	13.1M
Liabilities And Stockholders Equity	28.5M	54.2M	79.4M	40.8M	31.3M	29.7M
Other Stockholder Equity	260.9M	297.3M	336.5M	337.5M	342.3M	359.4M
Total Liab	2.8M	1.7M	1.8M	1.3M	4.9M	4.6M
Total Current Assets	8.3M	34.0M	59.3M	40.2M	29.1M	30.5M
Common Stock	36K	71K	98K	8K	10K	9.5K
Other Current Liab	7K	61K	12K	362K	1.8M	1.7M
Property Plant And Equipment Net	1.1M	1.1M	931K	616K	2.1M	2.2M
Other Current Assets	169K	399K	568K	2.2M	1.8M	930.3K
Property Plant And Equipment Gross	1.1M	1.1M	2.4M	2.2M	3.9M	4.1M
Short Long Term Debt Total	817K	596K	534K	297K	1.9M	1.6M
Non Current Liabilities Total	537K	379K	298K	57K	1.6M	1.5M
Short Term Debt	280K	217K	236K	240K	216K	205.2K
Net Tangible Assets	6.6M	33.4M	58.5M	39.6M	35.6M	34.6M
Other Assets	50K	544K	46K	0.0	1.0	0.95
Retained Earnings Total Equity	(138.0M)	(187.1M)	(235.3M)	(244.9M)	(220.4M)	(209.4M)
Capital Surpluse	243.4M	253.9M	260.9M	297.3M	341.9M	215.9M
Property Plant Equipment	1.1M	1.1M	931K	616K	708.4K	640.6K
Net Invested Capital	25.7M	52.5M	77.5M	39.6M	26.4M	45.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Cocrystal Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cocrystal Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cocrystal Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Cocrystal Pharma Stock:

How To Invest In Cocrystal

Details

Is Cocrystal Stock a good investment?

Details

What is Cocrystal Pharma's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Note that the Cocrystal Pharma information on this page should be used as a complementary analysis to other Cocrystal Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Cocrystal Stock analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.

	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

Is Cocrystal Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.87)

Revenue Per Share

0.006

Quarterly Revenue Growth

0.269

Return On Assets

(0.37)

Return On Equity

(0.55)

The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cocrystal Cash vs Accounts Payable Analysis

Cash vs Accounts Payable

Cash vs Accounts Payable Correlation Analysis

Correlation Coefficient

Cash

Accounts Payable

Cocrystal Pharma fundamental ratios Correlations

Cocrystal Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cocrystal Pharma fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Cocrystal Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Assets Total	+ 0.98	Total Assets
Common Stock	+ 0.98	Common Stock Total Equity
Inventory	+ 0.98	Short Long Term Debt Total

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Common Stock	- 0.96	Non Currrent Assets Other
Common Stock Total Equity	- 0.96	Non Currrent Assets Other
Other Stockholder Equity	- 0.9	Retained Earnings